Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cortexyme Inc
(NQ:
CRTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 29, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cortexyme Inc
< Previous
1
2
3
4
Next >
Mid-Morning Market Update: Markets Open Higher; AT&T Earnings Top Expectations
January 26, 2022
Following the market opening Wednesday, the Dow traded up 1.14% to 34,689.16 while the NASDAQ rose 2.15% to 13,830.02. The S&P also rose, gaining, 1.61% to 4,426.80. The U.S....
Via
Benzinga
Cortexyme Stock Plunges On FDA Hold On Atuzaginstat's IND
January 26, 2022
The
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 26, 2022
Gainers Vaccinex (NASDAQ:VCNX) shares moved upwards by 30.4% to $1.33 during Wednesday's pre-market session. The market value of their outstanding shares is at $40.9...
Via
Benzinga
3 Most-Shorted Stocks at 52-Week Lows to Buy
January 07, 2022
In a market made up of stocks, these three most-shorted stocks look poised to deliver a much happier 2022 to bullish investors.
Via
InvestorPlace
Top Short Squeeze Plays
December 20, 2021
Since the market has dropped so much, now might be the time to look for short squeeze opportunities.
Via
Talk Markets
The 10 Most Shorted Stocks Right Now for Friday, Dec. 17
December 17, 2021
Shorted stocks continue to be of interest to retail traders looking for the next big day trade and we're diving into some top candidates!
Via
InvestorPlace
5 Short Squeeze Candidates To Watch: Pioneer Power, NuZee Remain At The Top, Grab Rejoins The Leaderboard
December 06, 2021
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYS...
Via
Benzinga
Could It Finally Be Time To Step Up to The Plate With GME Stock?
November 18, 2021
There's mixed messages being sent to bullish investors other than apes, but the next inning or two of play look promising for GME stock.
Via
InvestorPlace
Cassava Pops As Cortexyme Dives — Why One Alzheimer's Stock Is 'Back On Track'
November 11, 2021
An analyst says Cassava is on track, but Cortexyme took another beating Thursday.
Via
Investor's Business Daily
Why Are Cortexyme Shares Falling Today?
November 11, 2021
Cortexyme Inc (NASDAQ: CRTX) has presented additional data from its Phase 2/3 GAIN Trial at the Clinical Trials on Alzheimer's Disease Conference. The...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 11, 2021
Gainers Liquidia (NASDAQ:LQDA) stock inc...
Via
Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Commences Late-Stage Study Of Heart Failure Treatment Merck &...
Via
Benzinga
This Is What Whales Are Betting On Cortexyme
November 03, 2021
Someone with a lot of money to spend (and possibly insider knowledge) has taken a bullish stance on Cortexyme (NASDAQ:CRTX). And retail traders should know. We noticed this today...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
Down 76%: Is Cortexyme Stock a Bargain?
October 28, 2021
The biotech's stock took a big hit after its lead product candidate flunked a key clinical trial.
Via
The Motley Fool
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Cortexyme's Alzheimer's Drug Fails -- 2 Lessons for Investors
October 28, 2021
Another new drug candidate for the treatment of Alzheimer's disease failed miserably in a clinical trial.
Via
The Motley Fool
71 Biggest Movers From Yesterday
November 03, 2021
Gainers Avis Budget Group, Inc. (NASDAQ: CAR) shares climbed 108.3% to close at $357.17 on Tuesday after the company reported better-than-expected Q3 adjusted EPS and sales...
Via
Benzinga
CRTX Stock: What to Know as Cortexyme Plummets 75%
October 27, 2021
Today, investors in CRTX stock lament a rather poor announcement from the company that a key clinical trial missed its primary endpoint.
Via
InvestorPlace
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
64 Biggest Movers From Yesterday
October 28, 2021
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Surges Over 100 Points; Cortexyme Shares Plunge
October 27, 2021
Toward the end of trading Wednesday, the Dow traded down 0.23% to 35,674.01 while the NASDAQ rose 0.81% to 15,358.79. The S&P also rose, gaining 0.14% to 4,581.2. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Cortexyme Shares Are Falling
October 27, 2021
Cortexyme Inc (NASDAQ: CRTX) shares are trading lower after the company's Phase 2/3 GAIN trial did not meet its co-primary endpoints. Cortexyme says they will present the...
Via
Benzinga
Here's Why Cortexyme Is Imploding on Wednesday
October 27, 2021
An Alzheimer's disease trial failure was much worse than the company's relatively upbeat look forward suggests.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 27, 2021
Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock...
Via
Benzinga
Mid-Day Market Update: Dow Falls Over 100 Points; Silicon Laboratories Shares Spike Higher
October 27, 2021
Midway through trading Wednesday, the Dow traded down 0.30% to 35,648.39 while the NASDAQ rose 0.32% to 15,283.97. The S&P also fell, dropping 0.03% to 4,573.51. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Mid-Morning Market Update: Markets Rise; Coca-Cola Tops Q3 Views
October 27, 2021
Following the market opening Wednesday, the Dow traded up 0.16% to 35,814.95 while the NASDAQ rose 0.24% to 15,271.98. The S&P also rose, gaining 0.12% to 4,580.19. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2021
October 27, 2021
Upgrades According to Credit Suisse, the prior rating for Mercer International Inc (NASDAQ:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 27, 2021
Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
October 27, 2021
Raymond James raised Alphabet Inc. (NASDAQ:GOOGL
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.